Clinical Trial Update: A Study to Assess the Pharmacokinetics, Safety and Efficacy of Advagraf and Prograf in de Novo Liver Transplantation [Phase 4]

View source ↗

Summary

This Phase 4 study assesses the pharmacokinetics, safety, and efficacy of Advagraf (tacrolimus extended-release) versus Prograf (tacrolimus) in de novo liver tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Transplantation

Drugs mentioned

• Advagraf (tacrolimus)
• Prograf (Tacrolimus)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Liver Transplantation | Phase 4 | Status: COMPLETED